Neurons in the olfactory epithelium (OE) each express a single dominant olfactory receptor (OR) allele from among roughly 1,000 different OR genes. While monogenic and monoallelic OR expression has been appreciated for over two decades, regulators of this process are still being described; most recently, epigenetic modifiers have been of high interest as silent OR genes are decorated with transcriptionally repressive trimethylated histone 3 lysine 9 (H3K9me3) whereas active OR genes are decorated with transcriptionally activating trimethylated histone 3 lysine 4 (H3K4me3). The lysine specific demethylase 1 (LSD1) demethylates at both of these lysine residues and has been shown to disrupt neuronal maturation and OR expression in the developing embryonic OE. Despite the growing literature on LSD1 expression in the OE, a complete characterization of the timing of LSD1 expression relative to neuronal maturation and of the function of LSD1 in the adult OE have yet to be reported. To fill this gap, the present study determined that LSD1 (1) is expressed in early dividing cells before OR expression and neuronal maturation and decreases at the time of OR stabilization; (2) colocalizes with the repressor CoREST (also known as RCOR1) and histone deacetylase 2 in these early dividing cells; and (3) is required for neuronal maturation during a distinct time window between activating reserve stem cells (horizontal basal cells) and Neurogenin1 (1) immediate neuronal precursors. Thus, this study clarifies the role of LSD1 in olfactory neuronal maturation.
Gradwohl, Fode, & Guillemot, 1997; Cau, Casarosa, & Guillemot, 2002; Manglapus, Youngentob, & Schwob, 2004; Guo et al., 2010; Packard, Giel-Moloney, Leiter, & Schwob, 2011a) . After terminal mitosis, immature OSNs express the growth-associated protein-43 (GAP-43) (Verhaagen et al., 1989) , while full functional maturation apparently coincides with the expression of the olfactory marker protein (OMP) ( Fig. 1) (Farbman & Margolis, 1980; Schwob, Szumowski, Stasky, Mieleszko Szumowski, & Stasky, 1992) . Placing OR expression within the process of neuronal maturation, OR mRNA is first detectable in immature GAP-43 (1) OSNs by in situ hybridization, but quantitative analysis suggests that OR detection lags the initiation of GAP-43 expression (Iwema & Schwob, 2003) .
With regard to OR expression during neuronal differentiation, Greer and colleagues determined that ORs first appear at 4 days post cell division, lagging 3 days behind GAP43 expression (Rodriguez-Gil et al., 2015) . These data suggest that the latest possible time for OR choice is at the immature OSN stage, concomitant with OR mRNA expression. However, OR choice may precede OR mRNA expression, and could occur earlier within the GBC progression. Other data suggest that choice is not fixed at that stage. For example, OR switching apparently occurs in immature OSNs; moreover, mRNA from multiple ORs is present in immature OSNs by single-cell RNA-seq (Lewcock & Reed, 2004; Shykind et al., 2004; Hanchate et al., 2015; Saraiva et al., 2015; Tan et al., 2015; Scholz et al., 2016) . In fact, single-unit recordings have shown that immature OSNs are more broadly responsive to odorants before becoming increasingly selective during the transition from immature to mature OMP (1) OSNs (Gesteland, Yancey, & Farbman, 1982) . In sum, the choice of OR, if made and implemented at the stage when neurons are still maturing, is impermanent or still in progress at that time.
The mechanisms underlying singular OR gene choice are likely to be multiple but will almost certainly involve both short and long range chromosomal interactions (including promoter sequences and enhancer regions) (Vassalli, Rothman, Feinstein, Zapotocky, & Mombaerts, 2002; Serizawa et al., 2003; Rothman, Feinstein, Hirota, & Mombaerts, 2005; Lomvardas et al., 2006) as well as negative feedback after the choice is made (Serizawa et al., 2003; Lewcock & Reed, 2004; Dalton, Lyons, & Lomvardas, 2013) . However, none of these mechanisms fully accounts for the initial selection of a single OR allele. More recently, epigenetic silencing of non-expressed ORs has been described and implicated in singular OR gene choice (Magklara et al., 2011) . Specifically, OR gene clusters are decorated with heterochromatic markers H3K9me3 and H3K20me3, and these transcriptional-silencing chromatin modifications are located on ORs in OSNs, sustentacular cells (Sus cells; supporting cells of the OE), and in Neurog1 (1) GBCs and immature neurons harvested from Neurog1-eGFP mice, but not in the reserve stem cell population, the HBCs (Magklara et al., 2011) . The fact that ORs sit within heterochromatin in non-neuronal Sus cells suggests that epigenetic OR silencing occurs before neuronal commitment, and therefore likely before OR gene choice. Importantly, actively expressed ORs lack H3K9me3 and are instead marked with the transcriptionally activating chromatin modification, H3K4me3 (Magklara et al., 2011) . Thus, the model has emerged where all ORs are initially silenced until only one OR allele is de-repressed and concomitantly activated (Magklara et al., 2011) . To flesh out this model fully, the key demethylases and methytransferases need to be identified that determine the chromatin state at OR alleles.
The lysine specific demethylase 1 (LSD1) has been nominated as a candidate epigenetic regulator of OR genes as it FIG URE 1 Stem and progenitor progression in the neuronal lineage. Horizontal basal cells (HBCs) are K5 (1) multipotent progenitors (MPPs) able to give rise to all cell types of the OE following activation. The GBC population can be subdivided into stages of progenitor capacity (Schwob et al., 2017) : GBCs that function as MPP express Sox2 and Pax6; GBCs that function as transit-amplifying neuronally committed cells (TA-N) express Ascl1; GBCs that function as immediate neuronal precursors (INP) express Neurog1. Immature OSNs express GAP-43 and mature OSNs express OMP. This study used CreER T2 drivers to conditionally delete Lsd1 in K5 (1) HBCs MPP ., Ascl1
demethylates at both H3K4me1/2 (functioning to repress) and H3K9me1/2 (having an activating effect) (Shi et al., 2004; Metzger et al., 2005; Garcia-Bassets et al., 2007; Laurent et al., 2015) . LSD1 activity on H3K4 vs. H3K9 is dictated by the binding partners with which it complexes: LSD1 can demethylate at H3K4 when associated with the REST corepressor 1 (CoREST1) (Lee, Wynder, Cooch, & Shiekhattar, 2005) and can demethylate at H3K9 in association with the androgen receptor, estrogen receptor, or supervillin (Metzger et al., 2005; Garcia-Bassets et al., 2007; Laurent et al., 2015) . It was recently reported that CoREST colocalizes with LSD1 in both the uninjured OE (Krolewski, Packard, & Schwob, 2013; Kilnic, Savarino, Coleman, Schwob & Lane, 2016 ) and in nuclear compartments in an olfactory placode-derived cell line (Kilinc et al., 2016) , suggesting that the LSD1/ CoREST complex could act at H3K4 to repress transcription.
LSD1 is demonstrable in the OE by immunohistochemistry, RNAseq, and microarray analysis and appears to be most abundant in GBCs (Krolewski et al., 2013; Lyons et al., 2013; Kilinc et al., 2016) . Therefore, LSD1 is likely present before, and potentially during, OR gene choice. To test for a role for LSD1 in OR gene choice, Lomvardas and colleagues knocked-out Lsd1 in mice under the control of three cellspecific drivers: Foxg1-Cre, MOR28-Cre, and OMP-Cre . Lsd1 knockout in MOR28 (1) and OMP (1) mature OSNs using the latter two drivers had no effect on OR gene choice, while knockout using the Foxg1-Cre driver, which is broadly activated in the embryonic OE, aborted OSN differentiation at the immature OSN stage and blocked OR expression. Ostensibly full maturation of a few OSNs could be rescued by transgene-driven overexpression of ORs, suggesting that the halt in neuronal maturation was secondary to the inability to express ORs . However, Foxg1-driven deletion of
Lsd1 results in perinatal lethality, limiting these experiments to embryonic development. Consequently, we sought to further characterize a role for LSD1 in the adult OE by knocking out LSD1 using tamoxifeninducible cell-specific drivers utilizing Cre recombinase fused to a mutated estrogen receptor fragment (CreER
T2
).
To enhance understanding of LSD1 function in the OE we focused on three main areas: (1) The timing of LSD1 expression relative to OSN maturation and OR expression; (2) The presence of LSD1 binding partners in LSD1 (1) cells in the mouse OE; and (3) The effect of inducible Lsd1 knockout in three basal cell populations: K5 (1) HBC MPPs , Ascl1
(1) GBC TA-Ns , and Neurog1 (1) GBC INPs . These experiments demonstrate that LSD1 is expressed in early dividing cells prior to OR expression and neuronal maturation, that LSD1 co-localizes with CoREST and histone deacetylase 2 (HDAC2) in these early dividing cells, and that LSD1 is required for neuronal maturation during the time window between activating HBCs and Neurog1 (1) immediate neuronal precursors.
| M A TE RI A L S A ND M E TH ODS

| Animals
Wild-type F1 mice bred in-house from C57/BJ6 and 129S1/Sv1MJ stocks or ordered from Jackson Laboratories (stock #101043) were used for LSD1 and CoREST co-labeling immunohistochemistry, Western blotting and immunoprecipitation, and for generation of control methyl bromide (MeBr)-lesioned tissue. Neurog1-eGFP BAC transgenic mice generated by the GENSAT project (Gong et al., 2003) were harvested for Neurog1 staining when uninjured or following olfactory bulbectomy. All EdU pulse-chase experiments were performed on bigenic M72-IRES-tauGFP/P2-IRES-taulacZ mice bred to congenicity with C57/ Bl6 mice, and originally gifted by Dr. Peter Mombaerts (Mombaerts et al., 1996; Feinstein & Mombaerts, 2004) . Floxed Lsd1 mice were generously provided by Dr. Michael Rosenfeld (Wang et al., 2007) 
| MeBr and methimazole lesion
Eight-week old male mice were exposed to MeBr gas (Matheson Gas Products, East Rutherford, NJ) for 8 hr at a concentration of 170 ppm in purified air at a rate of 10 L/min as previously described (Schwob, Youngentob, & Mezza, 1995) . Unilateral exposures were performed by plugging the left naris with a 5-mm piece of PE10 tubing and the lumen of the tube was obstructed with a knotted 5.0 suture thread (Schwob, Youngentob, Ring, Iwema, & Mezza, 1999) . Following lesion, mice were kept on the same feeding and housing schedule and were sacrificed at 2 days or 3 weeks after exposure.
Methimazole lesion (Bergman, € Ostergren, Gustafson, & Brittebo, 2002) was performed on male and female mice with a single intraperitoneal injection of 50 mg/kg methimazole in saline at a concentration of 10 mg/ml. Following injection, mice were kept on the same feeding and housing schedule and were perfused 2-weeks post lesion.
| Olfactory bulbectomy
Male and female mice were anesthetized with a double cocktail of ketamine (6.25 mg/kg) and xylazine (12.5 mg/kg). Once animals reached a surgical anesthetic plane, they were immobilized in a stereotactic head mount resting on a 378C heating pad. A single incision was made on shaved, disinfected skin to expose the overlying frontal bone and a bone drill was used to expose the right olfactory bulb; the bulb
| EdU and tamoxifen administration
To label dividing cells, EdU (ThermoFisher catalog # A10044) dissolved in sterile PBS was injected subcutaneously in 10-week old mice at 50 mg/kg body weight. Animals were sacrificed at 1, 2, 3, 5, 7, and 9 days post-EdU injection, and EdU was detected in 10 lm coronal sections via Click-iT® chemistry according to the manufacturer's instructions (ThermoFisher catalog # C10339).
Tamoxifen purchased from Sigma (#T5648) was dissolved in sterile USP-grade corn oil at 30 mg/ml by gentle inversion at 608C for 10 min; the dissolved tamoxifen was injected intraperitoneally at 150 mg/kg into 6-week-old mice once a day for two successive days. In lineage tracing experiments utilizing Ascl1 and Neurog1 CreER T2 drivers, mice were injected with methimazole the day after the second dose of tamoxifen. Previous work from our lab demonstrates that further delay between recombination and lesion means that the newly labeled progenitors will progress to terminal neuronal differentiation (Lin, Hewitt, Peterson & Schwob, 2015) .
Thus, methimazole lesion immediately following tamoxifen is necessary to modify the labeled Ascl1 (1) or Neurog1 (1) progenitors of interest.
| Tissue processing
Mice were anaesthetized by intraperitoneal injection of a lethal dose of a triple cocktail of ketamine (37.5 mg/kg), xylazine (7.5 mg/kg), and 
| Antibody specificity
Primary antibodies used in this study are shown in Table 1 . Information on the antibodies is derived from the manufacturers' description, the literature, and our own data.
Anti-b-actin from ThermoFisher was used for a loading control in Western blots. This antibody recognizes a single 42 kD band and has been used extensively in the literature (see ThermoFisher datasheet, cat #MA5-15379). An anti-b-galactosidase antibody was used to detect lacZ-tagged P2 OSNs; the observed P2 expression patterns match previous descriptions closely (Mombaerts et al., 1996) .
The rabbit anti-cytokeratin 14 (CK14) from ProteinTech robustly stains the HBCs and perfectly matches previous staining patterns reported for CK14 (1) cells in the OE, which expression was confirmed by 2-D Western blot (Holbrook, Szumowski, & Schwob, 1995) .
Mouse anti-CoREST from NeuroMab recognizes a single band at 55 kD by western blot of the OE (Fig. 4h ) and has been verified in
CoREST transfected Cos-1 cells (see NeuroMab datasheet, clone K72/ 8). Staining patterns using this antibody match previously reported
CoREST staining patterns in the OE (Krolewski et al., 2013) .
A rabbit monoclonal GAP43 antibody (Abcam) used to identify immature OSNs has been verified for staining in human brain tissue, mouse ear tissue, and in the rat dorsal root ganglion (Abcam datasheet, ab75810). The staining pattern observed for this antibody in the OE matches that of previously reported GAP43 antibodies (Verhaagen et al., 1989; Meiri, Bickerstaff, & Schwob, 1991) .
Chicken anti-GFP was used to detect M72-GFP OSNs and Neurog1-eGFP GBCs. This antibody has been used extensively for immunohistochemistry in the brain, olfactory bulb, and olfactory epithelium (Abcam datasheet, ab13970). M72 expression patterns using this antibody match those seen in our hands with other GFP antibodies as well as previously reported M72 expression patterns (Feinstein & Mombaerts, 2004) . Neurog1-eGFP staining patterns match that of the native GFP visualized prior to steam pretreatment, which destroys GFP fluorescence.
The mouse HDAC2 antibody recognizes a single 58 kD band in cell lysates from several cell lines including H3k293T, HeLa, and
Neuro-2a and stains human glioblastoma cell lines by immunofluorescence (Abcam datasheet, ab12169).
The rabbit polyclonal LSD1 antibody recognizes a single 98 kD band in the OE by Western blot (see Fig. 4h ). This antibody encompasses previously reported LSD1 staining patterns in the OE (Krolewski et al., 2013) , but is more sensitive than the antibody used in the prior publication. The currently used antibody was also utilized in other recent olfactory publications (Kilinc et al., 2016) . Cells that have undergone conditional LSD1 knock-out do not stain with this antibody (see
Figs. 6-10).
Goat anti-OMP from Santa Cruz Biotechnology was used to identify mature OSNs (Farbman & Margolis, 1980) . OMP (1) cells marked by this antibody are co-extensive with GFP (1) cells in OMP-GFP transgenic mice in our hands as previously reported (Krolewski et al., 2013 ).
The rabbit MOR28 antibody was generously provided by Gilad Barnea, Brown University . This antibody robustly stains MOR28 (1) cells and matches MOR28 patterns shown by in situ hybridization both in our hands and others .
Rabbit polyclonal anti-TdTomato (TdT) was used for lineage tracing experiments to detect TdT (1) cells after steam pretreatment; cells that stain for TdT by immunohistochemistry are the same as those identifiable by native fluorescence of the TdT reporter prior to steaming.
The mouse monoclonal antibody Tuj1 is highly selective for neuron-specific Class III b-tubulin and does not label other classes of b-tubulin. This antibody has been rigorously shown to stain immature OSNs Roskams, Cai, & Ronnett, 1998) . The BioLegend antibody used in this study is the same Covance Tuj1 antibody used by our lab previously (Krolewski et al., 2013; Jang, Chen, Flis, Harris, & Schwob, 2014) . and Cy3 conjugated streptavidin was used at 1:100. All secondary and tertiary antibodies were obtained from Jackson ImmunoReasearch where they were tested for minimal cross-reactivity.
| Immunohistochemistry
Prior to immunostaining, rubber cement was applied to encircle each section and dried onto the slide for 15 min on a hot plate; then slides were rinsed in PBS to remove OCT. Sections were subjected to antibody-specific pretreatments (Table 1 , where marked) for antigen retrieval including enzymatic digestion, hydrogen peroxide incubation (5 min in 3% H 2 O 2 in MeOH), and "steaming" in 0.01M, pH 6 citric acid buffer heated in a commercial food-steamer. Non-specific-binding was blocked by incubating with 10% donkey serum/5% non-fat dry milk/4% BSA/0.1% TritonX-100 in PBS. Primary antibodies were applied overnight at 48C. Subsequent visualization may entail one of an methods as indicated in Table 1 and including: (1) staining with directly conjugated secondary antibodies; (2) use of biotinylated secondary antibodies and fluorescently conjugated streptavidin; (3) enhancement using Tyramide signal amplification (TSA), all as described (Guo et al., 2010; Packard et al., 2011a; Schnittke et al., 2015) .
After labeling, slides were counter-stained in DAPI for 10 min, mounted in N-propyl gallate anti-fadent media, and cover-slipped. Slide edges were sealed with a thin layer of commercial-grade nail polish and stored at 2208C until imaging.
| Imaging and quantification
Images of EdU-marked cells were obtained with a Spot RT2 color digital camera attached to a Nikon 800E epiflourescent microscope. The remaining images were acquired on a Zeiss 510 confocal microscope in multi-track mode. Confocal images were first processed to adjust color palette, balance, and contrast using the Fiji package of ImageJ 1.50i software applied to the entire image before cropping and figure assembly in Adobe Photoshop CS5.1. Images obtained using the Nikon photomicroscope were assembled, cropped, and adjusted for brightness and contrast applied to the entire image in Photoshop directly.
Labeled cells were counted directly using the Nikon 800E epifluorescent microscope with a dual red/green fluorescent filter to allow simultaneous counting of single-and double-labeled cells. All cells included in counts contained nuclear profiles demonstrated via DAPI staining. For P2/EdU co-labeling experiments, eight evenly spaced sections through the anterior to posterior epithelium were counted; for the rest of the EdU co-staining experiments, four evenly spaced sections from levels 3 to 6 were analyzed. All cell counts were made in the P2-expressing regions of the OE excluding counts of OR28 (1) 
| Western Blotting and immunoprecipitation
Flash-frozen OE was suspended in lysis buffer (1M Tris pH 7.5, 0.5M EDTA, 1Xprotease and phosphatase inhibitors (ThermoFisher cat #79440), 20% Triton X-100, 0.5M NA 3 VO 4 , 2M NaCl) at 60 ll/mg of tissue, and sonicated until the tissue was homogenized. Membranes were removed by spinning at 14,000 rpm and a bicinchoninic acid assay (BCA) protein assay was used to determine protein concentrations; stocks of 2 mg/ml were made up in 1X SDS sample buffer (ThermoFisher cat # B0008) and 1X reducing agent (ThermoFisher cat #B0009) and frozen at 2808C until used for Western blotting. Samples were denatured at 958C for 5 min and loaded at 40 lg/lane. Electrophoretically separated proteins were transferred to PVDF transfer using the Bolt Mini Blot Module (ThermoFisher cat #B1000 TBST/5% milk 6 times for 5 min and secondary HRP conjugated antibodies (Jackson ImmunoResearch) were incubated at 1:1,000 for 1 hr at room temperature. After two 30-min washes, the membrane was incubated in ECL substrate (ThermoFisher cat #34080) and developed.
For immunoprecipitation, samples were lysed by sonication in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS< 50 mM Tris, pH 8.0). Following BCA protein quantification, the protein was diluted to 1 mg/300 ll and incubated with anti-LSD1 primary antibody at 1:100 overnight at 48C with rotation. The NAb Protein G spin kit was used for immunoprecipitation as described by the manufacturer (ThermoFisher cat#89949). During Western blotting, primary antibodies were used at 1:5,000 and 1:500 for LSD1 and CoR-EST, respectively; secondary HRP conjugates were used at 1:2,000.
Gel electrophoresis, transfer, and development were performed as described above.
| R ESU L TS
| OR expression during OSN maturation
To analyze the relative timing of OR and LSD1 expression, we first characterized OSN maturation using EdU pulse-chase experiments, comparing EdU staining with that for GAP-43 to mark immature OSNs, and with that for OMP to mark mature OSNs, respectively (Fig. 2) .
GBCs are the predominant cycling cell within the OE, representing over 90% of the cells that incorporate thymidine analogues (including EdU) during S phase (Huard & Schwob, 1995; Salic & Mitchison, 2008) .
In the normal unlesioned OE, GBCs give rise exclusively to neurons, and incorporated thymidine analogue label can be chased from the Sphase progenitors into the neuronal population (Schwartz Levey, Chikaraishi, & Kauer, 1991; Caggiano, Kauer, & Hunter, 1994; Schwob, Huard, Luskin, & Youngentob, 1994; Huard & Schwob, 1995) . Because some among the GBC population may divide more than once (Huard & Schwob, 1995) , the time at which the leading edge of the doublelabeled cells appears represents the shortest interval between last mitosis and that stage in differentiation. All of the numbers listed below report the percent of double-labeled cells among the group of target cells that were counted.
For pulse-chase experiments, we injected EdU into 8-week old mice and waited 1, 2, 3, 5, 7, and 9 days post injection (DPI) to collect tissue for immunohistochemistry. GAP-43 (1)/EdU (1) cells were found in low numbers as early as 1 DPI, when an average of 2.5% of
EdU (1) were GAP-43 (1)/EdU (1) (Fig. 2c) . At 2 DPI, this percent increased to 8%, and a drastic jump occurred at 3 DPI with 40% of EdU (1) cells being co-immunolabeled for GAP-43 and EdU (Fig. 2c) .
GAP-43 (1)/EdU (1) cells peaked at 7 DPI to 60% before declining by 9 DPI back to 40%, likely reflecting the timeframe when GAP-43
(1) OSNs transition to OMP (1) OSNs (Fig. 2a, c) . By comparison, OMP (1)/EdU (1) cells were rare for the first few DPI, and then gradually increased to 11% at 5 DPI and 34% at 9 DPI, again demonstrating that the emergence of OMP (1) OSNs is beginning to accelerate at the end of that period (Fig. 2b, c) . For OMP and GAP43 EdU incorporation experiments, an average of 432 EdU (1) cells were counted for the group of animals at 1 DPI, 402 at 2 DPI, 348 at 3 DPI, 368 at 5 DPI, 411 at 7 DPI, and 359 at 9 DPI. These counts represent the average number of EdU (1) In like fashion, the timing of OR expression following basal cell division was determined by analyzing numbers of OR (1)/EdU (1) cells following EdU incorporation (Fig. 3) . In these experiments, we assayed three different ORs: (1) the P2 receptor, a Class II OR located on chromosome 7 and expressed in a ventral to ventrolateral swath of OE (Mombaerts et al., 1996) (Fig. 3a) ; (2) MOR28, a Class II OR located on Chromosome 14 and concentrated in the dorsolateral OE (Serizawa et al., 2003) (Fig. 3b) ; and (3) M72, a Class II OR located on Chromosome 9 and expressed in the dorsomedial OE (Feinstein & Mombaerts, 2004) (Fig. 3c) . In these experiments, we compared the number of OR
(1)/Edu (1) cells to both OR (1) and EdU (1) cells, respectively.
P2
(1)/Edu (1) cells were found as early as 2 DPI at an average of 0.04% of EdU (1) cells and an average of 0.15% of P2 (1) cells (Fig. 3d,   g ). P2 (1)/EdU (1) cells peaked at 5-7 DPI to 0.48% of EdU (1) cells and to 1.74% of P2 (1) cells (Fig. 3d, g ). At 9 DPI, the percentage of P2
(1)/EdU (1) (unilaterally) making our analysis quite variable, but nonetheless consistent with an onset of OR expression at 5 DPI (Fig. 3f, i ). GBCs and more immature neurons (Fig. 4) . Taking advantage of the specificity and enhanced sensitivity, we re-examined when and where LSD1 is expressed during OSN maturation using EdU pulse-chase experiments and whether LSD1 associates with its potential binding partner, CoREST, in the OE by co-immunostaining and coimmunoprecipitation.
| LSD1 expression during OSN maturation
With respect to the timing of LSD1 expression, EdU pulse-chase experiments demonstrate that LSD1 (1)/EdU (1) cells are abundant at 1 DPI encompassing 74% of the EdU (1) cells (Fig. 4a, c) . With respect to subsequent stages, LSD1 (1)/EdU (1) cells remain high until 9 DPI at the time of OSN maturation to OMP (1) neurons (Figs. 2c, 4a , c).
For LSD1 and CoREST EdU-incorporation experiments, an average of 287 EdU (1) cells were counted in the group of animals at 1 DPI, 310 at 2 DPI, 254 at 3 DPI, 230 at 5 DPI, 224 at 7 DPI, and 219 at 9 DPI.
These counts represent the average number of EdU (1) (Fig. 4b, c) . The surmised LSD1/CoREST co-localization was directly assessed and validated (Fig. 5 ).
Both proteins are co-expressed in the vast majority of LSD1-labeled basal cells in the normal OE, which are situated immediately superficial to the CK14 (1)/LSD1 (2)/CoREST (2) HBCs (Fig. 5G ). For example, LSD1 and CoREST co-label Neurog1-eGFP (1) GBC INPs and Tuj1 (1) immature OSNs (Fig. 5a, b, d , e). By immunohistochemistry, LSD1 and CoREST are also co-expressed at low levels in OMP (1) mature OSNs (Fig. 5c, f) . While the co-expression in mature OSNs was not previously reported (Krolewski et al., 2013) , our novel observation here, no doubt, reflects the enhanced sensitivity of the new LSD1
antibody.
The immunostaining results are supported by the demonstration of both proteins in Western blots of normal OE tissue (Fig. 5h) . By comparison with our data on the timing of OR expression, LSD1 and
CoREST are detectable prior to OR expression (as defined by either coexpression of a marker protein or immunostaining for the OR) and full neuronal maturity, i.e., OMP expression (cf. Figs. 2-4) . Finally, we demonstrated that LSD1 and CoREST associate directly with one another in experiments that utilize immunoprecipation for LSD1 followed by Western blotting for CoREST (Fig. 5h, i) .
To characterize further the LSD1/CoREST complex that is present in GBC INPs , we immunostained for HDAC2, another member of this epigenetic silencing complex, and found that its expression is also almost completely co-extensive with that of LSD1 (Fig. 6) (Lee et al., 2005) .
Previous descriptions suggested that LSD1 expression patterns change following OE lesion (Krolewski et al., 2013) . Therefore, we assessed LSD1 and CoREST patterns in two injury models: olfactory bulbectomy (OBX), a lesion model that results in a loss of mature OSNs and an expansion of progenitors, and methylbromide (MeBr)-lesion, a lesion model that activates the HBC reserve stem cell population (Fig.   7 ). As expected, LSD1 (1) and CoREST (1) cells increased post OBX (Fig. 7a-d ), in line with previous publications demonstrating increases in Neurog1-eGFP (1) GBCs and immature OSNs following bulbectomy (Verhaagen et al., 1990; Schwob et al., 1992; Iwema & Schwob, 2003; Krolewski et al., 2013) . Both LSD1 and CoREST appear in CK14 (1) HBCs by 2 days after MeBr lesion ( Fig. 7e-h ), a finding previously reported by our lab using a different LSD1 antibody (Krolewski et al., 2013 
| K5-CreERT2 driver
For the first set of experiments, mice with the following genotype K5-
; R26Rfl(stop)TdTomato (TdT);Lsd1 fl/fl, were given tamoxifen at 6
weeks of age to excise Exon 6 of Lsd1 and induce heritable expression of the TdT reporter ( Fig. 8a) (Wang et al., 2007) . Two weeks later, the epithelium was lesioned by exposure to MeBr in order to activate dormant HBCs to multipotency and differentiation into GBCs. The tissue was then harvested 3 weeks post-injury, which allows adequate time for large numbers of HBC-derived TdT (1) progeny to mature into OMP (1) OSNs (Fig. 8b, c) . Close inspection of the tissue indicates that some TdT (1) ) at the Lsd1 locus, roughly 60% of the total number of counted TdT (1) neurons (OMP (1) and Tuj1 (1) cells inclusive) on average were OMP (1) at 3 weeks after MeBr lesion (Fig. 8c-f, i) . In contrast, in the homozygous conditional knockout animals (Lsd1
), only about of 6% of counted TdT (1) neurons were OMP (1) (Fig. 8g-i ). An average of 1,400 TdT (1) cells were counted per animal (n 5 3) across four sections that were evenly spaced from the anterior to the posterior OE (see Materials and Methods).
Despite taking the precaution of examining areas of the epithelium where recombination was maximally efficient, it remains possible that the counts include a few TdT (1) cells that retain one or more copies of the intact Lsd1 allele and potentially retain the ability to mature into OMP (1) OSNs. Thus, as noted above, the lower rate of recombination at the Lsd1 gene locus (as compared to the ROSA26-TdT allele) leads to the interpretation that the small numbers of TdT (1) cells that reach full maturation and OMP expression in the Lsd1 fl/fl mice most likely reflect the failure to delete one or both alleles at the Lsd1 locus, i.e., the small minority of the TdT (1) cells that achieve OMP expression in the homozygous mice are not likely to be null for Lsd1.
Our results demonstrate that LSD1 is required for the progression from activated HBC to fully mature, OMP (1) OSNs. Our findings phenocopy the results obtained with Foxg1-driven excision of LSD1 in early development . Within the Lsd1 animals, we did not observe a deficiency in Sus cell production, suggesting that LSD1 is specifically required for neuronal maturation within the OE.
To rule out any contribution that MeBr lesion might make specifically to the failure of neuronal maturation, we took advantage of the very low, but noticeable activation of HBCs following ablation of the olfactory bulb. Thus, we bulbectomized K5-CreER
T2
; R26Rfl(stop)TdTomato (TdT); Lsd1 fl/fl mice (Fig. 9 ). Once again, in the Lsd1 fl/fl animals, neurons failed to mature to express OMP while adjacent cells were able to express OMP (Fig. 9c-f ).
| Ascl1-CreER T2 driver
For the second set of experiments, mice with the following genotype, , were also given tamoxifen at 6 weeks of age to excise Exon 6 of Lsd1 and induce heritable expression of the TdT reporter, in order to interrogate LSD1 function at and after the Ascl1 (1) GBC TA-N stage (Figs. 10-11 ). In these experiments, we assessed neuronal maturation both in the unlesioned OE ( Fig. 10) and following direct epithelial injury by injection of methimazole (Bergman et al., 2002) (Fig. 11) MeBr because the recovery following MeBr lesion is relatively delayed.
As was true of the K5-driver, we observed incomplete recombination at the Lsd1 locus in the Ascl-CreER T2 mice despite robust recombination at the ROSA26 locus, such that some of the TdT (1) basal cells and neurons retained detectable LSD1 in the mice bearing the homozygous knockout allele; however, 93% of the marked neurons did lack detectable LSD1 and were often found in contiguous swathes of the epithelium, particularly in methimazole-lesioned animals (Figs. 10g2, 11g2 ). Thus, for purposes of determining the likelihood of neuronal maturation following Lsd1 knock out, we again screened for TdT (1)/LSD1 (2) regions and counted adjacent sections for TdT, OMP, and Tuj1. As for the K5 driver, the percentage of TdT (1)/OMP (1) neurons (as proportion of total OSN counts) was markedly reduced in the Lsd1 homozygous conditional knock-out animals under both unlesioned and lesioned conditions as compared to mice that were wild-type or heterozygous for the floxed Lsd1 allele (Figs. 10i, 11i) . In animals that were either wild-type or heterozygous at the Lsd1 locus, an average of 85% (under non-lesioned conditions) and 70% (under lesioned conditions) of the total number of counted TdT (1) OSNs were OMP (1) at 2 weeks post-tamoxifen/lesion (Figs. 10i, 11i ). In contrast, in the homozygous conditional knockout animals (Lsd1
), only 25% of total counted TdT (1) OSNs were OMP (1) under both unlesioned and lesioned conditions (Figs. 10i, 11i) . Roughly 830 TdT (1) neurons were counted per uninjured animal and 930 TdT (1) cells were counted per lesioned mouse across four sections evenly spaced along the AP axis of the nose (n 5 3) (see Materials and Methods). As do the results following recombination in HBCs, these data demonstrate that cells that lack LSD1 expression during the GBC stage fail to mature and do not express OMP, whereas cells that retain LSD1 immunoreactivity do (Fig.   11g ).
| Neurog1-CreER T2 driver
For the third set of experiments, mice with the following genotype
; R26Rfl(stop)TdTomato (TdT); Lsd1 fl/fl, were given tamoxifen at 6 weeks of age to interrogate LSD1 function at and after the Neurog1 (1) GBC INP stage (Fig. 12) . In like fashion to the Ascl1-
; R26Rfl(stop)TdTomato (TdT) experiments, we lesioned the OE by injection of methimazole immediately following tamoxifen administration to assess the consequences of epithelial damage on the behavior of the maturing GBCs INP while they were progenitors. Once again, we observed differential Cre recombination at Lsd1 and the ROSA26-TdT reporter loci whereby the LSD1 was eliminated with an efficiency of 85% in the homozygous conditional knockout mice, for which we compensated as described above.
Lsd1 knockout in Neurog1 (1) GBCs INP under both basal and lesioned conditions did not interfere with the maturation of the OSNs that were progeny of the targeted GBCs (Fig. 12) . Unlike either dormant HBCs or in Ascl1 (1) GBCs TA-N , Neurog1 (1) GBCs INP following
Lsd1 excision were capable of maturing into OMP (1) OSNs during the same timeframe to the same extent as in both Lsd1 1/1 and Lsd1 fl/1 control animals (Fig 12c-j) . Roughly 930 TdT (1) cells were counted per uninjured animal and 890 TdT (1) cells were counted per lesioned animal across four sections evenly spaced along the AP axis of the nose (n 5 3) (see Materials and Methods). In mice that are homozygous for the floxed Lsd1 allele, nearly 100% of TdT (1) neurons in the unlesioned OE and greater than 80% of TdT (1) neurons in the methimazole-lesioned/recovered OE express OMP (Fig. 12g, h ).
We examined the kinetics of Cre recombination in both the Ascl1-CreER T2 and Neurog1-CreER T2 driver strains by monitoring TdT labeling at short survivals post-tamoxifen. The appearance of TdT serves as a surrogate for the assessing the timing of Lsd1 exon 6 gene excision relative to the progression of Ascl1 (1) and Neurog1 (1) GBC populations toward terminal neuronal differentiation (Fig. 13) . With the Ascl1-CreER T2 driver, we found that at 1 day post-tamoxifen administration, 37% of the TdT (1) cells remained within the GBC population and expressed NeuroD1 protein (37%), dropping to 12% by 2 days posttamoxifen administration (Fig. 13a, c) . As expected, the Neurog1-CreER T2 driver progressed more rapidly to neuronal differentiation, with 47% being NeuroD1 (1) at 6 hr after injection, and dropping to 11% by 1 day post-tamoxifen administration (Fig. 13b, c) . Thus, a 
| D I SCUSSION
The results presented here demonstrate the timing of critical events in the maturation of OSNs in the adult OE subsequent to the incorporation of EdU by proliferating GBC progenitors, including the initiation of neuronal differentiation as marked by the expression of GAP-43, neuronal maturation as marked by OMP, and the emergence of immunodetectable or marker-associated OR expression (Fig. 14) . For each stage, there tends to be a gradual increase and then a relatively abrupt inflection of the labeling index as a function of time. Thus, although a few differentiating neurons are seen 1 day after the EdU pulse, their numbers sharply increase between 2 and 3 days after injection. Likewise, mature OSNs are apparent, though sparse, by 3 days followed by the major accumulation between 7 and 9 days of pulse-chase. As expected from previous work from this lab and others (Iwema & Schwob, 2003; Rodriguez-Gil et al., 2015) , OR (1) neurons become evident between those two time-points, offset by about 2 days relative to the curve mapping GAP-43 (1) neurons as a function of time. These data present more granularity than available from previous studies of the adult OE (Iwema & Schwob, 2003) , and their concordance with data obtained in the context of early development (Rodriguez-Gil et al., to a thymidine pulse (Rodriguez-Gil et al., 2015) ; this discrepancy may be due to the fact that the experiments were performed at different developmental time points-10-week old adult mice in our hands versus 7-day old mice (Rodriguez-Gil et al., 2015) . Also important is the opportunity to compare the timing of these events to the expression of LSD1, given the suggestion that it acts as a key regulator of OR expression and singularity .
Within the context of neuronal maturation and OR expression, both LSD1 and one of the proteins with which it complexes, CoREST, are highly expressed in dividing GBCs, reach peak expression 5 days post-EdU pulse and then begin to decline by 7 days, which is around the time immature, GAP-43 (1) OSNs transition to mature, OMP (1) OSNs (Fig. 14) . Thus, both proteins anticipate terminal mitosis and the initiation of OR expression, and decrease at full neuronal maturation.
Thus, on temporal grounds, LSD1 could play a role prior to, at the time of, or during a short time-window following OR gene expression. However, LSD1 may not play a role achieving or maintaining OR singularity, since its expression declines precipitously when neurons express OMP, preceding the expression of a single OR (Shykind et al., 2004; Hanchate et al., 2015; Tan et al., 2015) .
That LSD1 and CoREST anticipate OR expression by several days is consistent with a hypothesized role in suppressing OR transcription prior to OR gene choice. For example, the association of LSD1 and
CoREST demonstrated by co-immunoprecipitation and, putatively, of HDAC2, is most consistent with a suppressive effect given the established role for the complex in other settings (Lee et al., 2005; Shi et al., 2005) . However, the initial multiplicity of OR expression in OMP (1) OSNs, at which point LSD1 levels have already decreased, suggest additional players are involved in establishing the final singularity.
Nonetheless, the appearance of LSD1 and CoREST in HBCs that are undergoing activation in response to epithelial injury is similarly suggestive that some type of early suppression is underway as the HBCs transition into GBCs. Consistent with that notion is the absence of H3K9me3 at OR loci in HBCs, which contrasts with their deposition in GBCs INP and immature OSNs (Magklara et al., 2011) . Unfortunately, the methylation status of OR-associated H3K4s has not been defined in HBCs.
It should be noted, however, that LSD1 is not exclusively associated with gene repression. Indeed, LSD1/CoREST complexes that replace HDAC2 with C-terminal binding protein (CtBP) have been found to activate transcription at select genes (Ray, Li, Metzger, Schule, & Leiter, 2014) . Thus, a second role for LSD1 in activating the OR locus eventually selected for singular expression has also been posited . Furthermore, LSD1 compartmentalizes in early postmitotic cells (immature OSNs) and co-localizes with 1-3 OR loci during this timeframe, suggesting that LSD1 may in fact modify specific OR alleles at the time of OR gene choice (Kilinc et al., 2016) . Given the duality of LSD1 function at both H3K4 and H3K9, it is very possible that LSD1 plays a key role in both repression and activation of OR genes at different time-points during OSN maturation. This idea was previously posited based on observations that LSD1 overexpression in mature OSNs decreased OR expression ; however, the concept of LSD1 repression of OR genes prior to OR gene choice has received little attention.
In light of the complexities of LSD1 and CoREST expression in the OE and in other tissues, we knocked out Lsd1 in adult epithelium using three different progenitor cell drivers: K5, which is expressed in HBCs, the population of dormant reserve stem cells (Leung et al., 2007; Fletcher et al., 2011; Packard, Schnittke, Romano, Sinha, & Schwob, 2011b; Schnittke et al., 2015; Schwob et al., 2017) ; Ascl1, which is expressed in GBCs that are usually described as transit amplifying progenitors (Cau et al., 1997; Manglapus et al., 2004; Schwob et al., 2017) ; Neurog1, which is expressed in GBCs that are usually described as progenitors that are immediate precursors of post-mitotic, differentiating, immature OSNs (Cau et al., 2002; Manglapus et al., 2004; Schwob et al., 2017) . We found that Lsd1 deletion in HBCs and in GBCs driven by Ascl1 aborts OSN maturation at the immature neuronal stage, which complements our observation that LSD1 and CoREST expression remain high through the period of neuronal immaturity (Fig. 14) . Thus, LSD1 is playing an important role in gene regulation during neurogenesis in the adult OE, as in the embryo .
Lsd1 deletion driven by Neurog1, on the other hand, did not disrupt OSN maturation, as cells with Lsd1 deletion at or after this stage make the transition into OMP (1) OSNs (Fig. 14) . It is perhaps surprising that Lsd1 excision in the immediate neuronal precursors does not share the maturational phenotype given the abundant expression of LSD1 in this cell type as well as immature neurons (Krolewski et al., 2013; Lyons et al., 2013; Kilinc et al., 2016 differentiation at which loss of LSD1 no longer blocks full neuronal maturation needs to take into account the half-life of the protein following successful gene deletion. In more specific terms, has neuronal maturation become independent of LSD1 at the GBC INP stage, or is it required until the neuron emerges as post-mitotic? Although a definitive answer cannot be provided at this point, some previously published and currently presented data suggest that LSD1 independency for OSN maturation emerges among cell that are still GBCs. First, the half-life of LSD1 in cells is 6-8 hr (Cao et al., 2016) , suggesting that by 24 hr after excision, the abundance of the protein is likely reduced below the concentration required for efficacy. Second, some GBCs remain TdT (1) beyond 1 day after tamoxifen administration to Neurog1-CreER T2 mice, yet 100% of the neurons mature in the uninjured OE (with extremely low variability). Furthermore, that only 85% mature in the context of the methimazole-lesioned OE fits with data indicating that a proportion of Neurog1 (1) GBCs assume multipotency in that setting Schwob et al., 2017) and is consistent with locating the blockade to differentiation upstream of the immediate neuronal precursor stage. Third, following recombination in the Ascl1-CreER T2 mice, some GBCs have progressed to the immediate neuronal precursor stage in the unlesioned OE 1 day after tamoxifen treatment;
that extent of neurogenic progression parallels the finding that a quarter of the TdT (1) neurons generated in these mice do mature fully.
Taken together, our data demonstrate a critical time window for LSD1-dependent neuronal maturation that begins as HBCs activate and terminates prior to the high-level expression of LSD1 in immature OSNs (Fig. 14) . The results also suggest, but do not fully prove that the transition to LSD1 independency for purposes of OSN maturation occurs at the Neurog1 (1) GBC INP stage.
It seems unlikely that the disruption in neuronal maturation caused by Lsd1 deletion at an early stage in the progenitor cell hierarchy is due exclusively to abnormalities of OR gene expression; that hypothesis is not especially consistent with either the substantial interval between recombination in the progenitors and OR expression by immature OSNs or the lack of effect of LSD1 depletion when ORs are first detected in immature neurons (Iwema & Schwob, 2003; Shykind et al., 2004) . At the very least, given that the amelioration of the phenotype anticipates OR expression, these data suggest that LSD1 is playing a role in repressing OR expression. For example, if LSD1 acts to remove methyl groups at H3K4me1/2 in upstream neuronal progenitors, the halt in maturation may be due to the overexpression of multiple OR genes. This multiplicity, in turn, might have consequences for axon targeting to and on the olfactory bulb, thereby disrupting the transition to OMP expression and/or depriving the mutant OSNs of the trophic support needed for long-term survival. Further investigation into OR multiplicity under the background of Lsd1 knockout and into the status of H3K4 epigenetic marks in HBCs and upstream progenitors in the presence and absence of LSD1 will be needed to clarify the nature of the defect.
Furthermore, the effect of Lsd1 knockout on neuronal maturation may be completely independent of an OR phenotype. In fact, LSD1 has been shown to be required for terminal differentiation (from precursor cells) in several cell types including pituitary cells, adipocytes, photoreceptor cells, gastrointestinal endocrine cells, hematopoietic cells, and neurons (Saleque, Kim, Rooke, & Orkin, 2007; Wang et al., 2007; Musri et al., 2010; Sun et al., 2010; Ray et al., 2014; Laurent et al., 2015; Popova, Pinzon-Guzman, Salzberg, Zhang, & Barnstable, 2015) . Thus, future studies are necessary to fill in the gaps between LSD1 removal and the halt in OSN maturation.
In summary, the current data demonstrate that LSD1 and its CoR-EST complex components are abundantly expressed before OR expression and OSN maturation, and that LSD1 is required for terminal differentiation during a distinct developmental time-frame extending from the point when upstream GBCs emerge from activated HBCs to the point at which GBCs reach the stage of functioning as immediate neuronal precursors. Future studies will reveal whether this maturational phenotype in the adult OE is dependent on OR gene regulation.
